ESR1 and breast carcinoma: Since the initial results point towards progestin-dependent increase of proliferation in ERα/PR-positive PGRMC1-overexpressing cell lines, we hypothesized that progestin-mediated PGRMC1 signaling is dependent on factors present in luminal cell types of breast cancer.